MI HB6288

Prescribers holding a controlled substances license may administer or dispense schedules 2-5 controlled substances without a separate license for those activities.

Beginning March 31, 2019, prescribers must maintain a bona fide prescriber-patient relationship before prescribing schedules 2-5 controlled substances, requiring in-person or telehealth evaluation and follow-up care monitoring.

Before prescribing controlled substances exceeding a 3-day supply (effective June 1, 2018), prescribers must obtain and review a report from Michigan's electronic monitoring system for schedules 2-5 substances.

Controlled substances prescribed for epilepsy or seizure disorder treatment and FDA-approved for that indication are exempt from the 3-day supply reporting requirement.

Prescribers dispensing controlled substances must maintain separate records for 5 years including acquisition invoices, dispensing logs, and disposition records, and must register with the state's electronic monitoring system.